advertisement
Radcliffe N 26
Showing records 1 to 25 | Display all abstracts from Radcliffe N104372 Energy Dose-Response in Selective Laser Trabeculoplasty: A Review
Radcliffe N
Journal of Glaucoma 2022; 31: e49-e68
104361 Evidence-Based Consensus Guidelines Series for MicroPulse Transscleral Laser Therapy: Dosimetry and Patient Selection
Grippo TM
Clinical Ophthalmology 2022; 16: 1837-1846
104339 First Real-World, Multicenter, Post-Marketing, Retrospective Study of Dexamethasone Intraocular Suspension for Inflammation After Cataract Surgery
Bacharach J
Clinical Ophthalmology 2022; 16: 1783-1794
104361 Evidence-Based Consensus Guidelines Series for MicroPulse Transscleral Laser Therapy: Dosimetry and Patient Selection
de Crom RMPC
Clinical Ophthalmology 2022; 16: 1837-1846
104372 Energy Dose-Response in Selective Laser Trabeculoplasty: A Review
Gazzard G
Journal of Glaucoma 2022; 31: e49-e68
104339 First Real-World, Multicenter, Post-Marketing, Retrospective Study of Dexamethasone Intraocular Suspension for Inflammation After Cataract Surgery
McCabe C; Jackson M
Clinical Ophthalmology 2022; 16: 1783-1794
104372 Energy Dose-Response in Selective Laser Trabeculoplasty: A Review
Samuelson T
Journal of Glaucoma 2022; 31: e49-e68
104361 Evidence-Based Consensus Guidelines Series for MicroPulse Transscleral Laser Therapy: Dosimetry and Patient Selection
Giovingo M; Töteberg-Harms M
Clinical Ophthalmology 2022; 16: 1837-1846
104372 Energy Dose-Response in Selective Laser Trabeculoplasty: A Review
Khaw P
Journal of Glaucoma 2022; 31: e49-e68
104339 First Real-World, Multicenter, Post-Marketing, Retrospective Study of Dexamethasone Intraocular Suspension for Inflammation After Cataract Surgery
Rao S; Singh IP
Clinical Ophthalmology 2022; 16: 1783-1794
104372 Energy Dose-Response in Selective Laser Trabeculoplasty: A Review
Sun X
Journal of Glaucoma 2022; 31: e49-e68
104361 Evidence-Based Consensus Guidelines Series for MicroPulse Transscleral Laser Therapy: Dosimetry and Patient Selection
Francis BA; Jerkins B
Clinical Ophthalmology 2022; 16: 1837-1846
104339 First Real-World, Multicenter, Post-Marketing, Retrospective Study of Dexamethasone Intraocular Suspension for Inflammation After Cataract Surgery
Heersink S
Clinical Ophthalmology 2022; 16: 1783-1794
104372 Energy Dose-Response in Selective Laser Trabeculoplasty: A Review
Aung T
Journal of Glaucoma 2022; 31: e49-e68
104339 First Real-World, Multicenter, Post-Marketing, Retrospective Study of Dexamethasone Intraocular Suspension for Inflammation After Cataract Surgery
Radcliffe N
Clinical Ophthalmology 2022; 16: 1783-1794
104372 Energy Dose-Response in Selective Laser Trabeculoplasty: A Review
Lam D
Journal of Glaucoma 2022; 31: e49-e68
104361 Evidence-Based Consensus Guidelines Series for MicroPulse Transscleral Laser Therapy: Dosimetry and Patient Selection
Brubaker JW
Clinical Ophthalmology 2022; 16: 1837-1846
104339 First Real-World, Multicenter, Post-Marketing, Retrospective Study of Dexamethasone Intraocular Suspension for Inflammation After Cataract Surgery
Weinstock R
Clinical Ophthalmology 2022; 16: 1783-1794
104372 Energy Dose-Response in Selective Laser Trabeculoplasty: A Review
Singh K
Journal of Glaucoma 2022; 31: e49-e68
104361 Evidence-Based Consensus Guidelines Series for MicroPulse Transscleral Laser Therapy: Dosimetry and Patient Selection
Radcliffe N
Clinical Ophthalmology 2022; 16: 1837-1846
104372 Energy Dose-Response in Selective Laser Trabeculoplasty: A Review
Katz LJ
Journal of Glaucoma 2022; 31: e49-e68
104361 Evidence-Based Consensus Guidelines Series for MicroPulse Transscleral Laser Therapy: Dosimetry and Patient Selection
An J
Clinical Ophthalmology 2022; 16: 1837-1846
104339 First Real-World, Multicenter, Post-Marketing, Retrospective Study of Dexamethasone Intraocular Suspension for Inflammation After Cataract Surgery
Paggiarino D
Clinical Ophthalmology 2022; 16: 1783-1794
104361 Evidence-Based Consensus Guidelines Series for MicroPulse Transscleral Laser Therapy: Dosimetry and Patient Selection
Noecker R
Clinical Ophthalmology 2022; 16: 1837-1846
104339 First Real-World, Multicenter, Post-Marketing, Retrospective Study of Dexamethasone Intraocular Suspension for Inflammation After Cataract Surgery
Patel K
Clinical Ophthalmology 2022; 16: 1783-1794
